Szombathelyi Z, Kárpáti E, Till A
Köbányai Gyógyszerárugyár, Farmakológiai Kutató Központ, Budapest.
Acta Pharm Hung. 1991 Jan;61(1):48-60.
Pathological, muscular arteries (common and superficial femoral [FC, FS], anterior and posterior tibial [TA, TP] arteries) of patients suffering from arteriosclerosis obliterans (ASO), thromboangiitis obliterans (TAO), and diabetes mellitus (DIA), removed during amputation of the lower limb were studied as isolated organs. The vessels were cut into transverse rings and contractile force was measured isometrically. The total number of used rings was 828. The following agonists were applied: KCl (80 mM), serotonin (5-HT) (10 microM), prostaglandin F2 alpha (PGF2 alpha) (0.1 mM) or phenylephrine (PE) (10 microM). It was established that applying KCl, 5-HT or PGF2 alpha, the majority of arterial rings display a contraction, but most of the preparations (66%) give no response against PE. The measure of contraction depends on the diagnosis (TAO greater than ASO greater than DIA), on the age of patient and also the anatomical location of the artery in the case of TAO (TP greater than greater than TA), on the associated hypertension in the case of ASO (normotensive greater than hypertensive) and finally on the time elapsed between the operation and usage of preparation if the agonist is KCl. As a conclusion, despite the terminal clinical stage the majority of studied human arteries retained at least a part of their functional integrity.
对因下肢截肢而切除的患有闭塞性动脉硬化(ASO)、血栓闭塞性脉管炎(TAO)和糖尿病(DIA)患者的病理性肌性动脉(股总动脉和股浅动脉[FC,FS]、胫前动脉和胫后动脉[TA,TP])作为离体器官进行了研究。将血管切成横向环,并等长测量收缩力。使用的环总数为828个。应用了以下激动剂:氯化钾(KCl)(80 mM)、5-羟色胺(5-HT)(10 microM)、前列腺素F2α(PGF2α)(0.1 mM)或去氧肾上腺素(PE)(10 microM)。结果表明,应用KCl、5-HT或PGF2α时,大多数动脉环会出现收缩,但大多数制剂(66%)对PE无反应。收缩程度取决于诊断(TAO>ASO>DIA)、患者年龄,对于TAO还取决于动脉在解剖学上的位置(TP>>TA),对于ASO取决于是否伴有高血压(血压正常者>高血压患者),最后对于KCl作为激动剂的情况取决于手术与制剂使用之间经过的时间。总之,尽管处于终末期临床阶段,但大多数研究的人体动脉至少保留了部分功能完整性。